Magainin-mediated disruption of stratum corneum lipid vesicles.
Kaushik
S
S
School of Chemical Engineering, Georgia Institute of Technology, Atlanta 30332-0100, USA.
Krishnan
A
A
Prausnitz
M R
MR
Ludovice
P J
PJ
D000818:Animals; D000890:Anti-Infective Agents / Q000493:pharmacokinetics / Q000494:pharmacology*; D023181:Antimicrobial Cationic Peptides / Q000493:pharmacokinetics / Q000494:pharmacology*; D001692:Biological Transport; D002417:Cattle; D004305:Dose-Response Relationship, Drug; D016503:Drug Delivery Systems / Q000379:methods; D000091344:Filaggrin Proteins; D005452:Fluoresceins / Q000493:pharmacokinetics / Q000494:pharmacology; D007202:Indicators and Reagents; D007381:Intermediate Filament Proteins; D008051:Lipid Bilayers / Q000378:metabolism*; D054806:Magainins; D012867:Skin / Q000187:drug effects / Q000378:metabolism*; D029867:Xenopus Proteins; D014982:Xenopus laevis
D000890:Anti-Infective Agents; D023181:Antimicrobial Cationic Peptides; D000091344:Filaggrin Proteins; D005452:Fluoresceins; D007202:Indicators and Reagents; D007381:Intermediate Filament Proteins; D008051:Lipid Bilayers; D054806:Magainins; D029867:Xenopus Proteins; C053301:magainin 2 peptide, Xenopus; C007740:fluorexon